The current financial score of Resmed Inc is 9.63. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.46B, representing a year-over-year increase of 8.58%, while its net profit experienced a year-over-year increase of 0.98%.
The current valuation score of Resmed Inc is 8.11. Its current P/E ratio is 23.65, which is 80.95% below the recent high of 42.79 and 25.74% above the recent low of 17.56.
The current earnings forecast score of Resmed Inc is 6.96. The average price target is 251.97, with a high of 320.00 and a low of 175.00.
The current price momentum score of Resmed Inc is 3.67. Currently, the stock price is trading between the resistance level at 255.84 and the support level at 227.29, making it suitable for range-bound swing trading.
The current institutional shareholding score of Resmed Inc is 5.00. The latest institutional shareholding proportion is 69.00%, representing a quarter-over-quarter increase of 3.69%.
The current risk assessment score of Resmed Inc is 8.05. The company's beta value is 0.83. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.